← All stocks

TG THERAPEUTICS, INC.

TGTX Net selling
CIK 0001001316 #1066 in the set updated 17 Sep 2026
Bought (120 mo)
$1.46M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$19.37M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$19.37M
36 of 36 sales
Net
−$17.91M
−$17.91M against sales at will

By person

10 insiders · 39 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Power Sean A
CFO
$6.93M (14)
−$6.93M
798,111
0.5214%
$43.86M
+127.1%
RA CAPITAL MANAGEMENT, L.P. entity
10% owner
$4.09M (1)
−$4.09M
12,629,868
8.25%
$694.14M
−1.2%
Lonial Sagar
Director
$2.15M (6)
−$2.15M
94,061
0.0615%
$5.17M
+135.2%
Echelard Yann
Director
$95.76K (1)
$2.22M (4)
−$2.13M
223,816
0.1462%
$12.30M
+157.1%
Charney Laurence N
Director
$2.13M (6)
−$2.13M
168,640
0.1102%
$9.27M
+75.8%
KENNEDY WILLIAM JAMES
Director
$566.49K (3)
−$566.49K
109,633
0.0716%
$6.03M
+0.6%
WEISS MICHAEL S
CEO
$1.36M (2)
$1.28M (2)
+$82.22K
24,212,300
15.82%
$1.33B
+20.5%
Hoberman Kenneth
Director
279,653
0.1827%
$15.37M
+221.8%
HUME DANIEL
Director
192,748
0.1259%
$10.59M
+208.6%
SCHOENEBAUM MARK
Director
125,949
0.0823%
$6.92M
+31.3%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 106
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 36
Transactions with no price 0
Shares from compensation/vesting 24,374,835
Sales filed before the plan box existed 19
History held since 1 Sep 2016